WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017064302) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/064302    International Application No.:    PCT/EP2016/074806
Publication Date: 20.04.2017 International Filing Date: 14.10.2016
IPC:
A61K 38/17 (2006.01), A61K 38/22 (2006.01)
Applicants: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) [FR/FR]; 101, rue de Tolbiac 75013 Paris (FR).
UNIVERSITÉ PARIS DIDEROT - PARIS 7 [FR/FR]; 5, rue Thomas Mann 75013 Paris (FR).
UNIVERSITÉ DE ROUEN NORMANDIE [FR/FR]; 1 RUE THOMAS BECKET 76130 MONT-SAINT-AIGNAN (FR)
Inventors: TAN, Yossan-Var; (FR).
ABAD-RABAT, Catalina; (FR).
COUVINEAU, Alain; (FR).
VOISIN, Thierry; (FR)
Agent: COLLIN, Matthieu; (FR)
Priority Data:
15306657.6 16.10.2015 EP
16305146.9 08.02.2016 EP
Title (EN) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASES
(FR) MÉTHODES ET COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES AUTO-IMMUNES
Abstract: front page image
(EN)The present invention relates to methods and pharmaceutical compositions for the treatment of autoimmune inflammatory disease. In particular, the present invention relates to a method of treating an autoimmune inflammatory disease in a subject in need thereof comprising administering to the subject a therapeutically effective amount of at least one OX1R agonist.
(FR)La présente invention concerne des méthodes et des compositions pharmaceutiques pour le traitement d'une maladie inflammatoire auto-immune. En particulier, la présente invention concerne une méthode de traitement d'une maladie inflammatoire auto-immune pour un patient dont l'état le nécessite, consistant à administrer audit patient une quantité thérapeutiquement efficace d'au moins un agoniste d'OX1R.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)